Richardson Financial Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$71K Buy
643
+71
+12% +$6.86K 0.04% 278
2026
Q2
$44.8K Buy
572
+54
+10% +$3.68K 0.03% 327
2026
Q1
$33.5K Buy
518
+150
+41% +$10.6K 0.02% 356
2025
Q4
$24.8K Sell
368
-56
-13% -$3.77K 0.01% 382
2025
Q3
$31.1K Buy
424
+198
+88% +$13.2K 0.02% 328
2025
Q2
$12K Sell
226
-71
-24% -$4.04K 0.01% 388
2025
Q1
$19K Sell
297
-3
-1% -$174 0.01% 327
2024
Q4
$14.4K Buy
300
+40
+15% +$2.05K 0.01% 363
2024
Q3
$13.6K Hold
260
– – 0.01% 377
2024
Q2
$13.6K Buy
+260
New +$11.4K 0.01% 356

Other funds holding HALO

Richardson Financial Services's HALO Position: Q3 2026 in Review

Richardson Financial Services increased its Halozyme (HALO) stake by 12% in Q3 2026, buying an estimated $6.86K and bringing the position to 643 shares worth $71K. The position accounts for 0.04% of the portfolio, ranked #278.

Richardson Financial Services first reported a position in HALO in Q2 2024 and has held it in 10 quarters since. 777 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Richardson Financial Services held 643 shares of Halozyme worth $71K as of Q3 2026.
  • Richardson Financial Services bought 71 Halozyme shares in Q3 2026, an estimated $6.86K.
  • Halozyme made up 0.04% of Richardson Financial Services's portfolio in Q3 2026, its #278 holding.
  • Richardson Financial Services first reported a position in Halozyme in Q2 2024 and has held it in 10 quarters since.
  • 777 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Richardson Financial Services's 13F filing for Q3 2026, filed 30 Oct 2026.